Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research
There are well-described sex-based differences in how the immune system operates. In particular, cisgender (cis) females have a more easily activated immune system; associated with an increased prevalence of autoimmune diseases and adverse events following vaccinations. Conversely, cis males have a...
Main Authors: | Alice A. White, Ashleigh Lin, Xander Bickendorf, Blake S. Cavve, Julia K. Moore, Aris Siafarikas, Deborah H. Strickland, Jonatan Leffler |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/20420188221139612 |
Similar Items
-
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
by: Gloria Aranda, et al.
Published: (2021-09-01) -
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
by: Esteban Sánchez-Toscano, et al.
Published: (2023-09-01) -
Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults
by: Arjee Restar, et al.
Published: (2022-09-01) -
Breast cancer in a transgender woman undergoing gender-affirming exogenous hormone therapy
by: Michael D. Villalba, DO, et al.
Published: (2023-07-01) -
The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand
by: Sakditat Ittiphisit, et al.
Published: (2022-06-01)